636 related articles for article (PubMed ID: 28987849)
1. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
2. Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.
Valery CA; Faillot M; Lamproglou I; Golmard JL; Jenny C; Peyre M; Mokhtari K; Mazeron JJ; Cornu P; Kalamarides M
J Neurosurg; 2016 Dec; 125(Suppl 1):89-96. PubMed ID: 27903189
[TBL] [Abstract][Full Text] [Related]
3. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
4. Parameters influencing local control of meningiomas treated with radiosurgery.
Kaprealian T; Raleigh DR; Sneed PK; Nabavizadeh N; Nakamura JL; McDermott MW
J Neurooncol; 2016 Jun; 128(2):357-64. PubMed ID: 27131883
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
6. Gamma Knife surgery of meningiomas located in the posterior fossa: factors predictive of outcome and remission.
Starke RM; Nguyen JH; Rainey J; Williams BJ; Sherman JH; Savage J; Yen CP; Sheehan JP
J Neurosurg; 2011 May; 114(5):1399-409. PubMed ID: 21214335
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
10. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
11. Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma.
Zhou H; Bai HX; Chan L; Zhang PJ; Karakousis G; Huang R; Xiao B; Yang L
World Neurosurg; 2019 Nov; 131():e303-e311. PubMed ID: 31356979
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
13. Is Fractionated Gamma Knife Radiosurgery a Safe and Effective Treatment Approach for Large-Volume (>10 cm
Han MS; Jang WY; Moon KS; Lim SH; Kim IY; Jung TY; Jung S
World Neurosurg; 2017 Mar; 99():477-483. PubMed ID: 28017757
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
[TBL] [Abstract][Full Text] [Related]
18. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
[TBL] [Abstract][Full Text] [Related]
19. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
Champeaux C; Dunn L
World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
[TBL] [Abstract][Full Text] [Related]
20. Management of Meningiomas Involving the Major Venous Sinuses: A Single-Institution Experience.
Mohammed N; Narayan V; Patra D; Savardekar AR; Riaz M; Nanda A
World Neurosurg; 2019 Jul; 127():e179-e185. PubMed ID: 30878750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
